These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25369299)

  • 1. Molecular profiling of liver tumors: classification and clinical translation for decision making.
    Pinyol R; Nault JC; Quetglas IM; Zucman-Rossi J; Llovet JM
    Semin Liver Dis; 2014 Nov; 34(4):363-75. PubMed ID: 25369299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
    Li S; Mao M
    Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of genomic information in the clinical management of HCC.
    Quetglas IM; Moeini A; Pinyol R; Llovet JM
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):831-42. PubMed ID: 25260311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genome sequencing of the liver cancer genome.
    Nakagawa H; Shibata T
    Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations in hepatocellular carcinoma: An update.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular classification of hepatocellular carcinoma anno 2011.
    van Malenstein H; van Pelt J; Verslype C
    Eur J Cancer; 2011 Aug; 47(12):1789-97. PubMed ID: 21612914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signatures and prognosis of hepatocellular carcinoma.
    Hoshida Y
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):311-22. PubMed ID: 21769080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular perspectives for the treatment of hepatocellular carcinoma.
    Demory A; Nault JC
    Acta Gastroenterol Belg; 2020; 83(2):309-312. PubMed ID: 32603051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early molecular and genetic determinants of primary liver malignancy.
    Feitelson MA; Pan J; Lian Z
    Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle.
    Bhoori S; Toffanin S; Sposito C; Germini A; Pellegrinelli A; Lampis A; Mazzaferro V
    J Hepatol; 2010 May; 52(5):771-5. PubMed ID: 20347502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
    Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
    J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of hepatobiliary carcinogenesis.
    Nault JC; Zucman-Rossi J
    Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in molecular classification and precision oncology in hepatocellular carcinoma.
    Rebouissou S; Nault JC
    J Hepatol; 2020 Feb; 72(2):215-229. PubMed ID: 31954487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another key molecule for pathogenesis of hepatocellular carcinoma.
    Tada M; Omata M
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1803-4. PubMed ID: 20002936
    [No Abstract]   [Full Text] [Related]  

  • 15. Multivariate analysis of several molecular markers and clinicopathological features in postoperative prognosis of hepatocellular carcinoma.
    Zuo Q; Huang H; Shi M; Zhang F; Sun J; Bin J; Liao Y; Liao W
    Anat Rec (Hoboken); 2012 Mar; 295(3):423-31. PubMed ID: 22190283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
    Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
    Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma.
    Imbeaud S; Ladeiro Y; Zucman-Rossi J
    Semin Liver Dis; 2010 Feb; 30(1):75-86. PubMed ID: 20175035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
    Lim HY; Sohn I; Deng S; Lee J; Jung SH; Mao M; Xu J; Wang K; Shi S; Joh JW; Choi YL; Park CK
    Ann Surg Oncol; 2013 Nov; 20(12):3747-53. PubMed ID: 23800896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
    Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
    Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.